May 29, 2025 12:44 PM EDT
Pharma
Law

Ei­sai, Mer­ck stave off gener­ic com­pe­ti­tion to block­buster can­cer drug Lenvi­ma

Alexis Kramer

Deputy Editor

Ei­sai and Mer­ck suc­ceed­ed in stop­ping Shilpa Medicare Ltd. from launch­ing a gener­ic ver­sion of Lenvi­ma for at least an­oth­er decade, Ei­sai said Thurs­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sum­mit says bis­pe­cif­ic miss­es over­all sur­vival in close­ly-watched lung can­cer study

Sum­mit’s dis­ap­point­ing sur­vival read­out rais­es stakes for full da­ta

An­oth­er Bris­tol My­ers ex­ec goes to Aca­dia; David South­well takes CEO job at ARCH-backed can­cer biotech

Sanofi, Re­gen­eron re­port un­der­whelm­ing COPD da­ta for IL-33 an­ti­body, shares drop

Q&A: Why for­mer Sen. Kyrsten Sine­ma is back­ing a psy­che­del­ic med­i­cine with po­ten­tial­ly more up­side, but more risk

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times